CYP2C19药物遗传测试对预测西托洛普拉姆和埃斯基托洛普拉姆耐受性和有效性的影响:一个回顾性,纵向的队列研究
Mahmood Mahajna1,2, Rami Abu Fanne3,4, Matitiahu Berkovitch5
1Department of Clinical Pharmacy, The Hebrew University, Jerusalem 9112002, Israel.
Biomedicines
|December 23, 2023
概括
CYP2C19基因型影响了在患有严重抑郁症的患者中埃斯基塔洛普拉姆和西塔洛普拉姆的有效性. 基因检测可以预测治疗反应和副作用,从而使个性化医疗获得更好的结果.
科学领域:
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
背景情况:
- 酶CYP2C19会代谢抗抑郁药,如西塔洛普拉姆和埃斯基塔洛普拉姆.
- 在CYP2C19的遗传变异可以改变药物度,影响治疗的疗效和耐受性.
- 了解这些变异对于管理严重抑郁症 (MDD) 至关重要.
研究的目的:
- 评估CYP2C19基因型对埃斯基塔洛普拉姆和西塔洛普拉姆在MDD门诊患者的疗效和耐受性的影响.
- 根据新陈代谢状态和治疗结果确定患者子组.
主要方法:
- 对283名MDD患者进行了回顾性队列研究,其中CYP2C19基因定型.
- 药物不良反应的分析,使用比例概率,多级回归模型.
- 隐性类分析 (LCA) 用于识别与CYP2D6/CYP2C19代谢状态相关的患者子组.
主要成果:
- 较低的药物不耐受性几率与较高的CYP2C19活性评分 (OR=0.73) 有关.
- LCA确定了两个不同的患者组:一个具有多种副作用和低遵守性 (61.85%),另一个具有较少副作用和良好的遵守性 (38.15%).
- CYP2C19表型显著预测了群体成员资格.
结论:
- 基于 CYP2C19 基因型的活性评分与埃斯基塔洛普拉姆/西塔洛普拉姆的疗效和耐受性呈正相关性.
- LCA揭示了CYP2C19表型对患者坚持,耐受和反应的预测价值.
- 使用CYP2C19基因造型的个性化药物提供了一种有希望的方法来优化抗抑郁药物治疗并最大限度地减少副作用.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
152
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
152
Antidepressant Drugs: Overview
507
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
507
Factors Affecting Drug Biotransformation: Biological
153
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
153
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
264
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
264
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Hepatic Drug Clearance: Role of Transporters
60
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
60


